<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01474226</url>
  </required_header>
  <id_info>
    <org_study_id>0019850580</org_study_id>
    <secondary_id>CIHR, grant MT10321</secondary_id>
    <nct_id>NCT01474226</nct_id>
  </id_info>
  <brief_title>Metabolic Availability of Lysine From Rice</brief_title>
  <official_title>Application of the Indicator Amino Acid Oxidation Technique for the Determination of Metabolic Availability of Lysine From Cooked Rice Protein in Adult Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hospital for Sick Children</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Hospital for Sick Children</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the digestibility of the amino acid lysine in
      cooked rice in adult men using stable isotope technique.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators objective is to determine the metabolic availability (MA) of lysine in
      cooked white rice protein using the indicator amino acid oxidation (IAAO) technique. Five men
      will receive graded levels (20, 40, and 60, and 70%) of the lysine requirement of 35 mg/kg/d
      as a crystalline AA mixture,and cooked rice protein (20, 40 and 60%), respectively.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">November 2011</completion_date>
  <primary_completion_date type="Actual">November 2011</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Metabolic Availability of lysine</measure>
    <time_frame>Baseline</time_frame>
    <description>3 breath samples will be taken to provide a baseline F13CO2 measurement (Level of phenylalanine oxidation). Breath samples will be collected and analyzed for 13CO2 enrichment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Metabolic Availability of lysine</measure>
    <time_frame>15 min after intake of the fourth hourly meal (before tracer infusion))</time_frame>
    <description>3 breath samples will be taken to provide a baseline F13CO2 measurement (Level of phenylalanine oxidation). Breath samples will be collected and analyzed for 13CO2 enrichment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Metabolic Availability of lysine</measure>
    <time_frame>30 min after intake of the fourth hourly meal (before tracer infusion))</time_frame>
    <description>3 breath samples will be taken to provide a baseline F13CO2 measurement (Level of phenylalanine oxidation). Breath samples will be collected and analyzed for 13CO2 enrichment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Metabolic Availability of lysine</measure>
    <time_frame>45 min after intake of the fourth hourly meal (before tracer infusion))</time_frame>
    <description>3 breath samples will be taken to provide a baseline F13CO2 measurement (Level of phenylalanine oxidation). Breath samples will be collected and analyzed for 13CO2 enrichment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Metabolic Availability of Lysine</measure>
    <time_frame>Post Tracer Infusion (between 150 and 240 min of tracer infusion)</time_frame>
    <description>4 breath samples will be taken to provide F13CO2 measurement (Level of phenylalanine oxidation).Breath samples will be collected and analyzed for 13CO2 enrichment.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Healthy Adults</condition>
  <arm_group>
    <arm_group_label>Lysine Amino Acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Amino Acid Crystalline Lysine Amino Acid Mix</intervention_name>
    <description>crystalline lysine from AA MIX (20, 40, and 60% of the mean lysine requirement of 35 mg/kg/d) Lysine will be given in the form of L-Lysine-HCl, Sigma-Aldrich Brand.</description>
    <arm_group_label>Lysine Amino Acid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cooked Rice containing Lysine</intervention_name>
    <description>Lysine (20,40 and 60 % of the mean lysine requirement) from Cooked Rice</description>
    <arm_group_label>Lysine Amino Acid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy Adult males (18 to 50years old)

        Exclusion Criteria:

          -  A history of recent weight loss or illness

          -  Use of any medication at the time of entry into the study.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul B Pencharz, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hospital for Sick Children, Toronto, Canada</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G-1X8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2011</study_first_submitted>
  <study_first_submitted_qc>November 17, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2011</study_first_posted>
  <last_update_submitted>July 26, 2013</last_update_submitted>
  <last_update_submitted_qc>July 26, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 29, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Hospital for Sick Children</investigator_affiliation>
    <investigator_full_name>Dr. Paul Pencharz</investigator_full_name>
    <investigator_title>Professor of Paediatrics and Nutritional Sciences (Emeritus) University of Toronto, Senior Scientist Research Institute,The Hospital for Sick Children</investigator_title>
  </responsible_party>
  <keyword>lysine</keyword>
  <keyword>rice</keyword>
  <keyword>bioavailability</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

